The disease had poor prognosis, and the five-year survival rate is 5% to 20%
Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vzquez A, vila-Funes JA, Aguilar-Salinas CA (2019) Pathophysiological mechanisms linking type 2 diabetes and dementia: review of evidence from clinical, translational and epidemiological research
Cardiovasc Diabetol 24 , 87 (2025)
Several large-scale cardiovascular outcome trials (including LEADER, SUSTAIN-6, and REWIND) have shown that certain GLP-1 receptor agonists liraglutide, semaglutide, and dulaglutide reduce the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death in people with established cardiovascular disease or multiple cardiovascular risk factors
Designed as GLP-1 support vitamins in a powder form, they aim to complement a healthy diet and exercise routine for individuals focused on weight loss or weight management